These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 6123100)

  • 1. [Essential circulatory hyperkinesis and tobanum].
    Nagy I
    Orv Hetil; 1982 Feb; 123(9):569. PubMed ID: 6123100
    [No Abstract]   [Full Text] [Related]  

  • 2. [The effect of Tobanum (GYKI-41099) in essential circulatory hyperkinesis, studied by radiocardiography].
    Józan M; Tarján J; Wágner G; Rostás L; Lascsik L; Kovács S; Parti G
    Orv Hetil; 1981 Oct; 122(41):2547-8. PubMed ID: 6119668
    [No Abstract]   [Full Text] [Related]  

  • 3. Studies on a new beta-receptor blocking drug, tobanum--1-(2,5-dichlorophenoxy)-3-tertiary-butylamino-2-propanol HCl: its use in cardiovascular hyperkinetic syndrome, hypertension, and angina pectoris, and its effect on respiration.
    Szám I; Büky P; Gulyás A; Sinkovics M
    Int J Clin Pharmacol Ther Toxicol; 1982 Mar; 20(3):128-33. PubMed ID: 6121761
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Use of beta adrenergic receptor blockaders in industrial workers with neurocirculatory asthenia of the hypertensive type].
    Maziĭ SA; Senik EA; Turashvili GA; Zisel'man SB; Kazarian AB
    Sov Med; 1988; (7):96-9. PubMed ID: 3067385
    [No Abstract]   [Full Text] [Related]  

  • 5. [New drugs registered in Austria. Selectol].
    Rameis H
    Wien Klin Wochenschr; 1984 Apr; 96(8):299-302. PubMed ID: 6146230
    [No Abstract]   [Full Text] [Related]  

  • 6. [Therapeutic use of agents acting on alpha and beta receptors].
    Soballa G
    Fortschr Med; 1974 Apr; 92(11):461-6. PubMed ID: 4150787
    [No Abstract]   [Full Text] [Related]  

  • 7. [Indications for beta-blockers in other cardiac diseases: rhythm disorders, obstructive cardiomyopathy, cardiothyreosis and neurocirculatory asthenia].
    Guize L; Le Heuzey JY
    Rev Prat; 1984 Apr; 34(19):967-72. PubMed ID: 6144163
    [No Abstract]   [Full Text] [Related]  

  • 8. [Treatment of vegetovascular dystonia with beta-blockaders and tranquilizers].
    Zubarev IuG; Kulakov SA
    Sov Med; 1985; (3):83-5. PubMed ID: 2862710
    [No Abstract]   [Full Text] [Related]  

  • 9. [Hyperkinetic heart syndrome].
    Linss G
    Z Arztl Fortbild (Jena); 1985; 79(2):63-5. PubMed ID: 2859706
    [No Abstract]   [Full Text] [Related]  

  • 10. Clinical examination of the beta-adrenergic receptor blocking activity of Tobanum in spontaneously occurring anginas.
    Sipos Z; Hollósi Z; Iskum M
    Ther Hung; 1984; 32(2):74-8. PubMed ID: 6152819
    [No Abstract]   [Full Text] [Related]  

  • 11. [The effect of Tobanum on the electrophysiology of the heart].
    Tarján J; Rostás L; Wagner G; Józan M; Lascsik L
    Orv Hetil; 1981 Dec; 122(49):3005-8. PubMed ID: 6120494
    [No Abstract]   [Full Text] [Related]  

  • 12. [Length of effect of beta-blockers in hyperkinetic heart syndrome].
    Paulsen HF; Felder K
    ZFA (Stuttgart); 1983 Jul; 59(20):1149-54. PubMed ID: 6137915
    [No Abstract]   [Full Text] [Related]  

  • 13. Comparative study with Tobanum and Visken in hypertensive patients.
    Torma Z; Grubic V; Unyi G
    Ther Hung; 1983; 31(3):129-35. PubMed ID: 6152822
    [No Abstract]   [Full Text] [Related]  

  • 14. [Suloctidil (sulocton) in the treatment of atherosclerotic neurasthenic syndromes].
    Prusiński A; Kotwica S; Niewodniczy A; Split W
    Wiad Lek; 1982 May; 35(3-4):201-5. PubMed ID: 6287740
    [No Abstract]   [Full Text] [Related]  

  • 15. [Effect of butydrine in various clinical syndromes (cardiovascular neurosis: juvenile hyperkinetic syndrome; thyrotoxicosis)].
    Guardigli R
    Minerva Cardioangiol; 1970 Feb; 18(2):131-40. PubMed ID: 4393800
    [No Abstract]   [Full Text] [Related]  

  • 16. Editorial: Da Costa syndrome revisited.
    Vaisrub S
    JAMA; 1975 Apr; 232(2):164. PubMed ID: 235031
    [No Abstract]   [Full Text] [Related]  

  • 17. [Effect of propranolol and atenolol on peripheral tissue blood flow and effective plasma flow through the kidneys].
    Halawa B; Mazurek W
    Pol Tyg Lek; 1981 Jun; 36(22):797-9. PubMed ID: 7279762
    [No Abstract]   [Full Text] [Related]  

  • 18. [Effect of a short course of beta-blocker treatment on the central hemodynamics and work capacity of patients with neurocirculatory dystonia].
    Pal'tsev IS; Sokova EA; Fisenko LA
    Kardiologiia; 1985 Apr; 25(4):48-52. PubMed ID: 2862304
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Hyperkinetic heart syndrome].
    Lohmöller G; Lydtin H
    Fortschr Med; 1971 Aug; 89(22):864-7. PubMed ID: 4403734
    [No Abstract]   [Full Text] [Related]  

  • 20. Roentgen patterns of essential circulatory hyperkinesis.
    Csákány G; Varga L
    Radiol Diagn (Berl); 1965; 6(5):533-7. PubMed ID: 5882508
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.